Webcasts of the EGAM 2015 plenary session are available for viewing

The plenary session presented information on the evolving structure of the EORTC as well as the clinical research landscape and new forms of clinical research activities covering the full span from early clinical trials to survivorship. Exchanging views with other stakeholders and discussing the role of academia will be major highlights.

EGAM 2015 also marked a special celebration in honor of Françoise Meunier, Director General and her many significant contributions to the EORTC over the past two and a half decades.


General introduction, Roger Stupp

The patients perspectives and survival issues, Isabelle Lebrocquy

Cancer Management and Transatlantic cooperation, Richard Schilsky

The EORTC Charitable Trust, Diego du Monceau

EORTC future perspectives, Roger Stupp

Back to news list

Related News

  • Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types

  • Publication of 2022 EORTC Annual Report

  • EORTC is supporting Clinical Trials Day on 20th May

  • Studying long-term survivors of glioblastoma may pave the way to better treatment

  • Three new EORTC clinical trials funded by the EU

  • Important new results from EORTC to be presented at ESTRO 2023

  • EORTC QLG proudly collaborates on the EUonQoL project

  • HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer

  • EORTC: Working towards “Closing the Care Gap”

  • First international recommendations on the use of item libraries for patient-reported outcome measurement